Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Wakelee Shares Latest on Immunotherapy Agents, EGFR Inhibitors in Lung Cancer

August 4th 2017

Heather Wakelee, MD, discusses the latest developments with EGFR inhibitors and immunotherapy agents in non-small cell lung cancer.

Maintenance Olaparib Data Published as FDA Weighs Approval

August 1st 2017

The FDA granted a priority review in March to a new drug application for maintenance olaparib, and is scheduled to make its final decision on the PARP inhibitor before the end of the year.

Prostate Cancer: Advice for Oncologists on AR-V7 Testing

July 31st 2017

Experimental Strategies for AR-V7+ CRPC

July 31st 2017

Precision Medicine in mCRPC

July 31st 2017

Recent AR-V7 Data in Prostate Cancer

July 31st 2017

Prostate Cancer: Educating Physicians About AR-V7 Testing

July 31st 2017

Practical Implications of AR-V7 Testing in Prostate

July 31st 2017

Prostate Cancer: Validation of AR-V7 Testing

July 31st 2017

John's Hopkins AR-V7 Test in Prostate

July 31st 2017

Prostate Cancer: Epic Sciences AR-V7 Test

July 31st 2017

Detection of AR-V7 in Prostate Cancer

July 31st 2017

AR-V7 as a Predictive Marker in Prostate Cancer

July 31st 2017

Prostate Cancer: Discovery and Importance of AR-V7

July 31st 2017

The Biology of Prostate Cancer

July 31st 2017

Frontline Osimertinib Extends PFS in EGFR+ NSCLC

July 28th 2017

Frontline osimertinib (Tagrisso) significantly improved progression-free survival versus standard of care in patients with locally-advanced or metastatic EGFR-positive non–small cell lung cancer.

Unmet Needs in Kidney Cancer

July 17th 2017

Kidney Cancer: Non-Clear Cell Histology

July 17th 2017

Kidney Cancer: Vaccine-Based Approaches

July 17th 2017

Novel Combinations in Kidney Cancer

July 17th 2017